Tin tức & Cập nhật
Xem bài viết Ung thư
Xem

Secondary primary malignancies worsen multiple myeloma survival
While survival among multiple myeloma patients has been improving over time, the development of secondary primary malignancies seems to offset this effect by increasing the risk of mortality, a recent study has found.

T(11;14) translocation not linked to worse outcomes in multiple myeloma
In patients with multiple myeloma (MM), the chromosome translocation t(11;14) does not seem to be associated with worse prognosis, resulting in similar treatment outcomes as other standard-risk subgroups, reports a recent study.

Maintenance selinexor promising for PFS in advanced/recurrent endometrial cancer
Maintenance treatment with selinexor improved progression-free survival (PFS) in patients with advanced or recurrent endometrial cancer who had previously received first-line chemotherapy, particularly those with endometrioid histology and wild-type p53, according to a study presented at SGO 2022.

High blood pressure, Scarff Bloom-Richardson grade 3 predict CV events in breast cancer
Pre-existing cardiovascular disease (CVD) and grade 3 Scarff Bloom-Richardson are associated with the occurrence of cardiovascular (CV) events among women with breast cancer, reports a study.




